These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 28059425)

  • 21. Epstein-Barr Virus dUTPase Induces Neuroinflammatory Mediators: Implications for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Williams PhD MV; Cox B; Lafuse PhD WP; Ariza ME
    Clin Ther; 2019 May; 41(5):848-863. PubMed ID: 31040055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Why myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) may kill you: disorders in the inflammatory and oxidative and nitrosative stress (IO&NS) pathways may explain cardiovascular disorders in ME/CFS.
    Maes M; Twisk FN
    Neuro Endocrinol Lett; 2009; 30(6):677-93. PubMed ID: 20038921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum metabolomic profiling in acute alcoholic hepatitis identifies multiple dysregulated pathways.
    Rachakonda V; Gabbert C; Raina A; Bell LN; Cooper S; Malik S; Behari J
    PLoS One; 2014; 9(12):e113860. PubMed ID: 25461442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered Fatty Acid Oxidation in Lymphocyte Populations of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Maya J; Leddy SM; Gottschalk CG; Peterson DL; Hanson MR
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive Circulatory Metabolomics in ME/CFS Reveals Disrupted Metabolism of Acyl Lipids and Steroids.
    Germain A; Barupal DK; Levine SM; Hanson MR
    Metabolites; 2020 Jan; 10(1):. PubMed ID: 31947545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Examining clinical similarities between myalgic encephalomyelitis/chronic fatigue syndrome and D-lactic acidosis: a systematic review.
    Wallis A; Ball M; McKechnie S; Butt H; Lewis DP; Bruck D
    J Transl Med; 2017 Jun; 15(1):129. PubMed ID: 28592308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-associated DNA methylation patterns.
    Trivedi MS; Oltra E; Sarria L; Rose N; Beljanski V; Fletcher MA; Klimas NG; Nathanson L
    PLoS One; 2018; 13(7):e0201066. PubMed ID: 30036399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome.
    Landi A; Broadhurst D; Vernon SD; Tyrrell DL; Houghton M
    Cytokine; 2016 Feb; 78():27-36. PubMed ID: 26615570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased nuclear factor-κB and loss of p53 are key mechanisms in Myalgic Encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Morris G; Maes M
    Med Hypotheses; 2012 Nov; 79(5):607-13. PubMed ID: 22951418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential role of microbiome in Chronic Fatigue Syndrome/Myalgic Encephalomyelits (CFS/ME).
    Lupo GFD; Rocchetti G; Lucini L; Lorusso L; Manara E; Bertelli M; Puglisi E; Capelli E
    Sci Rep; 2021 Mar; 11(1):7043. PubMed ID: 33782445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-Metabolic Disease or Disturbed Homeostasis due to Focal Inflammation in the Hypothalamus?
    Hatziagelaki E; Adamaki M; Tsilioni I; Dimitriadis G; Theoharides TC
    J Pharmacol Exp Ther; 2018 Oct; 367(1):155-167. PubMed ID: 30076265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) severity on cellular bioenergetic function.
    Tomas C; Elson JL; Strassheim V; Newton JL; Walker M
    PLoS One; 2020; 15(4):e0231136. PubMed ID: 32275686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deep phenotyping of myalgic encephalomyelitis/chronic fatigue syndrome in Japanese population.
    Kitami T; Fukuda S; Kato T; Yamaguti K; Nakatomi Y; Yamano E; Kataoka Y; Mizuno K; Tsuboi Y; Kogo Y; Suzuki H; Itoh M; Morioka MS; Kawaji H; Koseki H; Kikuchi J; Hayashizaki Y; Ohno H; Kuratsune H; Watanabe Y
    Sci Rep; 2020 Nov; 10(1):19933. PubMed ID: 33199820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroinflammation in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An ¹¹C-(R)-PK11195 PET Study.
    Nakatomi Y; Mizuno K; Ishii A; Wada Y; Tanaka M; Tazawa S; Onoe K; Fukuda S; Kawabe J; Takahashi K; Kataoka Y; Shiomi S; Yamaguti K; Inaba M; Kuratsune H; Watanabe Y
    J Nucl Med; 2014 Jun; 55(6):945-50. PubMed ID: 24665088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attenuation of autoimmune responses to oxidative specific epitopes, but not nitroso-adducts, is associated with a better clinical outcome in Myalgic Encephalomyelitis/chronic fatigue syndrome.
    Maes M; Leunis JC
    Neuro Endocrinol Lett; 2014; 35(7):577-85. PubMed ID: 25617880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation.
    Maes M; Ringel K; Kubera M; Anderson G; Morris G; Galecki P; Geffard M
    J Affect Disord; 2013 Sep; 150(2):223-30. PubMed ID: 23664637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poor sleep quality is associated with greater circulating pro-inflammatory cytokines and severity and frequency of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) symptoms in women.
    Milrad SF; Hall DL; Jutagir DR; Lattie EG; Ironson GH; Wohlgemuth W; Nunez MV; Garcia L; Czaja SJ; Perdomo DM; Fletcher MA; Klimas N; Antoni MH
    J Neuroimmunol; 2017 Feb; 303():43-50. PubMed ID: 28038892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective Biomarkers from Plasma Metabolomics of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Implicate Redox Imbalance in Disease Symptomatology.
    Germain A; Ruppert D; Levine SM; Hanson MR
    Metabolites; 2018 Dec; 8(4):. PubMed ID: 30563204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.
    Bested AC; Marshall LM
    Rev Environ Health; 2015; 30(4):223-49. PubMed ID: 26613325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multi-'omics of gut microbiome-host interactions in short- and long-term myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Xiong R; Gunter C; Fleming E; Vernon SD; Bateman L; Unutmaz D; Oh J
    Cell Host Microbe; 2023 Feb; 31(2):273-287.e5. PubMed ID: 36758521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.